The Association of the British Pharmaceutical Industry (ABPI) has welcomed the new research guidance published by NHS England for the integrated care systems.
The guidance is said to reflect the benefits of delivering research, for patients, staff and healthcare system performance, including the economic benefits for the
NHS.
Jennifer Harris, ABPI's Director of Research Policy, said: "This guidance is clear on what good research practice looks like and it's great to see it out and
available for the NHS to use.
"A research-active NHS delivers huge value to patients, staff and the system itself. We hope that putting this guidance into action will help Integrated Care Systems
realise the huge benefits that research can offer, and help make the UK once again a destination of choice for developing the medical breakthroughs people need."